NUS Medicine researcher among newly selected 11 to join EMBO Global Investigator Network
Published: 13 Dec 2024
Assistant Professor Vincenzo Sorrentino from the Healthy Longevity Translational Research Programme (HL TRP) at the NUS Yong Loo Lin School of Medicine (NUS Medicine) has been selected as one of the newest members of the EMBO Global Investigator Network. This prestigious international network supports early-career scientists from around the world, providing them with financial resources for four years for networking activities and opportunities to collaborate with other prominent scientists.
Dr Sorrentino’s research at the HL TRP on targeting the mitochondria-proteostasis axis to promote healthy longevity is particularly relevant to Singapore, where the gap between life expectancy and healthy life expectancy poses significant challenges for one of the fastest aging populations in the world. As it stands, Singaporeans can expect to spend about nine years in ill health and with one in four Singaporean citizens be aged 65 and above by 2030, there is an urgent need for effective strategies to extend the healthspan of Singaporeans. Given that conditions such as sarcopenia and dementia are increasingly prevalent among Singapore’s elderly—affecting one in ten individuals over 60—Dr Sorrentino’s research will also be critical in identifying therapeutic targets that can mitigate these health issues.
EMBO, an organisation of over 2,100 leading researchers committed to advancing excellence in life sciences, has announced the selection of eleven scientists to join its prestigious Global Investigator Network. Representing India, Singapore, Taiwan, and Uganda, these researchers will receive financial support for collaboration and training opportunities, beginning their term in January 2025.
“Joining the EMBO Global Investigator Network is an exciting opportunity to connect with other leading researchers around the world and work together to tackle universal challenges such as aging. The support from EMBO will not only provide opportunities for my team members to grow professionally and enable me to contribute to the global healthy longevity field, but importantly, it will help build towards a healthier future for Singapore,” said Dr Sorrentino.
He is one of the eleven life scientists selected this year, joining a diverse group of researchers from India, Singapore, Taiwan, and Uganda. The EMBO Global Investigator Network comprises nearly 800 current and former members who are dedicated to addressing foundational research questions across various life sciences disciplines.
EMBO’s Global Investigator Network supports early-career group leaders by fostering connections within an international community of nearly 800 researchers. It offers funding for scientific meetings, collaborations, and visits to other institutions, as well as training courses, including lab leadership programmes.
“EMBO is excited to welcome the new EMBO Global Investigators. Their research highlights the universal language of discovery and provides diverse perspectives to tackle foundational research questions as well as global challenges,” said EMBO Director Fiona Watt.
More information here: www.embo.org
Read the press release here.
